Outcomes of Acute Myocardial Infarction in Nonagenarians

American Journal of Cardiology

Volumn 101, Issue 10, 2008, Pages 1379-1383

  Hovanesyan, Arsen ^a   Rich, Michael W ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATININE; HEMOGLOBIN; TROPONIN I;

ACUTE HEART INFARCTION; AGED; AGING; ARTICLE; BODY MASS; CAUCASIAN; CEREBROVASCULAR DISEASE; COMORBIDITY; CREATININE BLOOD LEVEL; DEMENTIA; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART CATHETERIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HOSPITAL MORTALITY; HUMANS; MALE; MISSOURI; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 42749084482     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.01.012     Document Type: Article

References (20)

1. th ed. (2001), Saunders, Philadelphia 2026
2. Projections of the total resident population by 5-year age groups, and gender with special age categories: middle series, 2050 -2070. Population Projections Program, Population Division (2000), U.S. Census Bureau, Washington, DC. www.census.gov/population/projections/nation/summary/np-t3-g.pdf January 13. Accessed February 26, 2008
3. White H.D., Barbash G.I., Califf R.M., Simes R.J., Granger C.B., Weaver W.D., Kleinman N.S., Aylward P.E., Goer J.M., Vahanian A., Lee K.L., Ross A.M., and Topol E.J. Age and outcome with contemporary thrombolytic therapy: results of the GUSTO-I trial. Global Utilization of Strepotokinase and TPA for Occluded coronary arteries trial. Circulation 94 (1996) 1826-1833
4. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
5. Antman E.M., Anbe D.T., Armstrong P.W., Bates E.R., Green L.A., Hand M., Hochman J.S., Krumholz H.M., Kushner F.G., Lamas G.A., Mullany C.J., Ornato J.P., Pearle D.L., Sloan M.A., and Smith Jr. S.C. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. J Am Coll Cardiol 44 (2004) 671-719
6. Bindra K., Berry C., Rogers J., Stewart N., Watts M., Christie J., Cobbe S.M., and Eteiba H. Abnormal haemoglobin levels in acute coronary syndromes. Q J Med 99 (2006) 851-862
7. Yamaguchi J., Kasanuki H., Ishii Y., Yagi M., Nagashima M., Fujii S., Koyanagi R., Ogawa H., Hagiwara N., Haze K., Sumiyoshi T., Honda T., and HIJC Investigators. Serum creatinine on admission predicts long-term mortality in acute myocardial infarction patients undergoing successful primary angioplasty: data from the Heart Institute of Japan Acute Myocardial Infarction (HIJAMI) Registry. Circ J 71 (2007) 1354-1359
8. Volpi A., De Vita C., Franzosi M.G., Geraci E., Maggioni A.P., Mauri F., Negri E., Santoro E., Tavazzi L., and Tognoni G. Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base. Circulation 88 (1993) 416-429
9. Becker R.C., Hochman J.S., Cannon C.P., Spencer F.A., Ball S.P., Rizzo M.J., and Antman E.M. Fatal cardiac rupture in patients treated with thrombolytic agents and adjunctive thrombin antagonists: Observations from the Thrombolysis and Thrombin in Myocardial Infarction 9 Study. J Am Coll Cardiol 33 (1999) 479-487
10. Hasdai D., Califf R.M., Thompson T.D., Hochman J.S., Ohman E.M., Pfisterer M., Bates E.R., Vahanian A., Armstrong P.W., Criger D.A., Topol E.J., and Holmes D.R. Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 35 (2000) 136-143
11. Berkowitz S.D., Granger C.B., Pieper K.S., Lee K.L., Gore J.M., Simoons M., Armstrong P.W., Topol E.J., and Califf R.M. Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction: the Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators. Circulation 95 (1997) 2508-2516
12. Krumholz H.M., Hennen J., Ridker P.M., Murillo J.E., Wang Y., Vaccarino V., Ellerbeck E.F., and Radford M.J. Use and effectiveness of intravenous heparin therapy for treatment of acute myocardial infarction in the elderly. J Am Coll Cardiol 31 (1998) 973-979
13. Skolnick A.H., Alexander K.P., Chen A.Y., Roe M.T., Pollack Jr. C.V., Ohman E.M., Rumsfeld J.S., Gibler W.B., Peterson E.D., and Cohen D.J. Characteristics, management, and outcomes of 5,557 patients age ≥90 years with acute coronary syndromes: results from the CRUSADE Initiative. J Am Coll Cardiol 49 (2007) 1790-1797
14. Buettner H.J., Mueller C., Gick M., Ferenc M., Allgeier J., Comberg T., Werner K.D., Schindler C., and Neumann F.J. The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 28 (2007) 1694-1701
15. Mehta L., Devlin W., McCullough P.A., O'Neill W.W., Skelding K.A., Stone G.W., Boura J.A., and Grines C.L. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol 99 (2007) 906-910
16. Kalantar-Zadeh K., Block G., and Horwich T. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol 43 (2004) 1439-1444
17. Krumholz H.M., Chen Y.T., Wang Y., and Radford M.J. Aspirin and angiotensin- converting enzyme inhibitors in elderly survivors of hospitalization for an acute myocardial infarction. Arch Intern Med 161 (2001) 538-544
18. Krumholz H.M., Radford M.J., Wang Y., Chen J., Heiat A., and Marciniak T.A. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project. JAMA 280 (1998) 623-629
19. Krumholz H.M., Radford M.J., Ellerbeck E.F., Hennen J., Meehan T.P., Petrillo M., Wang Y., Kresowik T.F., and Jencks S.F. Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries: patterns of use and outcomes. Circulation 92 (1995) 2841-2847
20. Schloss T.W., Gage B.F., and Rich M.W. An invasive strategy is associated with decreased mortality in patients 80 years and older with acute myocardial infarction. Am J Geriatr Cardiol 16 (2007) 84-91